drugset / Trial / NCT02757196
Treatment of ITP With Rituximab and / or Accutane
RandomizedCrossoverOpen-labelTreatment
Summary
a prospective, multicenter, randomized, open-label, Phase II, two arms interventional trial performed in 5 departments of hematology in China
Timeline
- Start
- 2016-05
- Primary completion
- 2017-12
- Completion
- 2018-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Methylprednisolone | Other / unclassified | 1 mg/kg | Oral |
| Subject | Rituximab | Monoclonal antibody | 1000 mg | Intravenous |